Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Avant Diagnostics, Inc. AVDX
Posted On: 06/04/2016 11:56:59 AM
Post# of 104
Avatar
Posted By: Mauibound
Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting

POSTER PRESENTATION #1
Sunday June 5, 8:00 AM – 11:30 AM CT

Abstract #558: Reverse-phase protein microarray (RPPA) analysis of PD-L1 and growth factor receptor signal transduction pathways in hormone receptor (HR)-positive primary breast cancer tissue and correlation with relapse.

Principle Investigator: Alan Lipton, MD, Penn State Hershey Medical Center
Presenter: Suhail M. Ali, MD, MBBS, Penn State Hershey Medical Center, VA Medical Center
Session: Breast Cancer-HER2/ER
Poster Display: Hall A; Poster Board 46; 8:00 AM – 11:30 AM CT

POSTER PRESENTATION #2
Monday June 6, 1:00 PM – 4:30 PM CT

Abstract # 11527: Androgen receptor activation in HER2-negative breast cancer liver metastases.

Principle Investigator: Joyce O’Shaughnessy, MD, Baylor University Center, Texas Oncology
Presenter: Corinne Ramos, Ph.D., Theranostics Health, Gaithersburg, MD
Session: Tumor Biology
Poster Display: Hall A; Poster Board 224; 1:00 PM – 4:30 PM CT

http://www.avantdiagnostics.com/news-media/pr...-2016-asco

Cheers













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site